# A Pharmacokinetic Study of the Effect of Itraconazole Exposure to Orvepitant in Healthy Volunteers

> **NCT03535662** · PHASE1 · COMPLETED · sponsor: **Nerre Therapeutics Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Pharmacokinetic Study in Healthy Male Volunteers

## Interventions

- **DRUG:** Orvepitant
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT03535662
- **Lead sponsor:** Nerre Therapeutics Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-08
- **Primary completion:** 2018-08-09
- **Final completion:** 2018-08-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03535662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03535662, "A Pharmacokinetic Study of the Effect of Itraconazole Exposure to Orvepitant in Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03535662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*